| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11011-018-0352-X |
| P698 | PubMed publication ID | 30506334 |
| P2093 | author name string | Saida Haider | |
| Syeda Madiha | |||
| P2860 | cites work | Pesticide exposure and Parkinson's disease: Epidemiological evidence of association | Q22251266 |
| Prevalence, etiology, and treatment of depression in Parkinson's disease | Q28191314 | ||
| Parkinson's disease: mechanisms and models | Q29547424 | ||
| Chronic systemic pesticide exposure reproduces features of Parkinson's disease | Q29614763 | ||
| Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. | Q30416797 | ||
| Well-water consumption and Parkinson's disease in rural California | Q33563011 | ||
| Age-related learning and memory deficits in rats: role of altered brain neurotransmitters, acetylcholinesterase activity and changes in antioxidant defense system | Q33848621 | ||
| Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature | Q34273182 | ||
| Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background | Q34430411 | ||
| Curcumin: from ancient medicine to current clinical trials. | Q34589151 | ||
| Present and future drug treatment for Parkinson's disease | Q35484805 | ||
| New insights into the mechanisms of antidepressant therapy | Q35729458 | ||
| Central monoamines and their role in major depression | Q35749568 | ||
| Depression in Parkinson's disease: conceptual issues and clinical challenges | Q35863400 | ||
| Kindling epileptogenesis in immature rats leads to persistent depressive behavior | Q35962188 | ||
| Antidepressant treatment of veterans with Parkinson's disease and depression: analysis of a national sample | Q36026290 | ||
| Effects of perinatal exposure to palatable diets on body weight and sensitivity to drugs of abuse in rats | Q36356994 | ||
| Targets for neuroprotection in Parkinson's disease | Q37302453 | ||
| Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis | Q37315448 | ||
| Lessons from the rotenone model of Parkinson's disease | Q37680293 | ||
| Development of curcumin as an epigenetic agent | Q37769504 | ||
| Depression in the patient with Parkinson's disease | Q37939173 | ||
| Depression in Parkinson disease--epidemiology, mechanisms and management. | Q37971293 | ||
| Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10. | Q38514050 | ||
| Depression in Parkinson's disease: a biochemical and organic viewpoint | Q40602150 | ||
| Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. | Q40606571 | ||
| Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells | Q40995755 | ||
| Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration | Q42680857 | ||
| GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice | Q42969383 | ||
| Microstructure of rat behavioral response to anxiety in hole-board. | Q42988166 | ||
| Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine | Q43024089 | ||
| Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats | Q44183832 | ||
| Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion | Q45075312 | ||
| Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years | Q45155172 | ||
| Peroxynitrite interaction with curcumin solubilized in ethanolic solution | Q45217597 | ||
| Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity | Q45778266 | ||
| Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin | Q46411318 | ||
| Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice | Q46647495 | ||
| Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats | Q46711011 | ||
| Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine | Q46727544 | ||
| Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease | Q46812957 | ||
| Beneficial effect of antidepressants against rotenone induced Parkinsonism like symptoms in rats | Q47627766 | ||
| Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism | Q48128398 | ||
| Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease. | Q48311920 | ||
| Changes in brain catecholamine levels following olfactory bulbectomy and the effect of acute and chronic administration of desipramine in rats | Q48335348 | ||
| Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | Q48446631 | ||
| Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor. | Q48478932 | ||
| Curcumin has neuroprotection effect on homocysteine rat model of Parkinson | Q48614825 | ||
| Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method. | Q52593494 | ||
| Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson's disease. | Q52857325 | ||
| Interaction between α-synuclein and other proteins in neurodegenerative disorders. | Q53324250 | ||
| “Behavioural despair” in rats and mice: Strain differences and the effects of imipramine | Q67016807 | ||
| Depressive symptoms in Parkinson's disease | Q80915141 | ||
| P433 | issue | 1 | |
| P921 | main subject | social interaction | Q609298 |
| toxic encephalopathy | Q7830379 | ||
| P304 | page(s) | 297-308 | |
| P577 | publication date | 2018-11-30 | |
| P1433 | published in | Metabolic Brain Disease | Q15764352 |
| P1476 | title | Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test | |
| P478 | volume | 34 |
Search more.